🔎 Trials Near Me

Domov › Metastatická rakovina › Ohio › Cleveland

Klinické štúdie Metastatická rakovina v meste Cleveland, OH

30 štúdií pre Metastatická rakovina hľadá účastníkov v zariadeniach v meste Cleveland a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Prebieha náborFáza 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07193511

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Prebieha náborFáza 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 míľ odtiaľ
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 míľ odtiaľ
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Prebieha náborFáza 1
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Prebieha náborFáza 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Prebieha náborFáza 1
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06234605

A Study of ASP3082 in Adults With Advanced Solid Tumors

Prebieha náborFáza 1
  • Case Western, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Prebieha náborFáza 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Prebieha náborFáza 3
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Prebieha náborFáza 3
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Prebieha náborFáza 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic, Cleveland
  • a 1 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213804

SLV-154 Treatment of Advanced Cancers

Prebieha náborFáza 1
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06771219

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Prebieha náborFáza 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Prebieha náborFáza 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT06566079

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Prebieha náborFáza 3
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Prebieha náborFáza 1
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT04913285

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Prebieha náborFáza 1
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07029399

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Prebieha náborFáza 3
  • Research Site, Cleveland
  • Research Site, Cleveland
Vek 18 a viac · Ženy · Aktualizované 29. 7. 2026 · NCT07044336

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Prebieha náborFáza 1
  • University Hospitals of Cleveland, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 7. 2026 · NCT05719558

REMASTer: REcurrent Brain Metastases After SRS Trial

Prebieha nábor
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT05124912

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1
  • Research Site, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT07284186

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Prebieha náborFáza 1
  • University Hospitals - UH Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 5. 2026 · NCT07094204

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Prebieha náborFáza 2/3
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Vek 18 a viac · Muži · Aktualizované 8. 4. 2026 · NCT04787744

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1/2
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 2. 2026 · NCT07030257

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Prebieha náborFáza 3
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 2. 2026 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Prebieha náborObservačná štúdia
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 míľ odtiaľ
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Prebieha náborFáza 1
  • University Hospitals Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2025 · NCT05808634

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Prebieha náborFáza 1
  • Case Western Reserve University, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 8. 2024 · NCT06548672

Štúdie Metastatická rakovina v iných mestách

Iné štúdie v Cleveland

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.